Pacific Sands, Inc. PFSD Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Pacific Sands, Inc. PFSD Company Overview 

Stock Message Board http://investorshangout.com/search?q=PFSD&...mp;yt1=Go!

Pacific Sands, Inc. PFSD Current Price and Quotes
Last Price 0.055
Previous Close 0.055 Open 0.055
Daily Range 0.055 - 0.055 52wk Range 0.11 - 0.04
Volume 5,000 Dividend N/A
Average Vol (3m) 12,924 Yield N/A
Pacific Sands, Inc. PFSD
Company Information

4611 Green Bay Road
Kenosha, WI 53144

Website: http://www.pacificsands.biz
Phone: 262-619-3261
Email: IR@PacificSands.biz

Pacific Sands, Inc. PFSD
We develop, manufacture, market and sell unique, nontoxic, earth, health and child-friendly products for cleaning, pet care and pool, spa and water maintenance applications. Our core, ecoONE, nontoxic product base utilizes a proprietary blend of botanicals, mineral extracts and enzyme technologies to deliver safe, effective and inexpensive nontoxic alternatives for a broad range of applications.

Pacific Sands, Inc. PFSD
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Mar 31, 2013 10-Q
CIK 0001069799
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3585 - Refrigeration and heating equipment
Business Status Development Stage Company a/o Sep 01, 2007
Incorporated In: NV, USA
Year of Inc. 1997
Employees 12 a/o Nov 16, 2010
Company Officers/Contacts

Michael Michie CEO, President
Company Directors

Not Available
Service Providers

Auditor/Accountant
Frank L. Sassetti & Co.
6611 W. North Ave
Oak Park, IL, 60302
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Pacific Sands, Inc. PFSD
PFSD Security Details

Share Structure

Market Value1 $3,546,483 a/o Sep 13, 2013
Shares Outstanding 64,481,505 a/o May 15, 2013
Float Not Available
Authorized Shares 100,000,000 a/o Dec 31, 2010
Par Value  0.001
Shareholders

Shareholders of Record 585 a/o Oct 15, 2012
Short Selling Data

Short Interest 0 (-100%)
May 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Corporate Stock Transfer, Inc.

Pacific Sands, Inc. PFSD Recent News

Aug 30, 2013 Pacific Sands, Inc. Announces Stock Repurchase
Jul 3, 2013 Pacific Sands, Inc. Reports Fiscal Fourth Quarter Revenue; Significant Sales Pipeline


Pacific Sands, Inc. PFSD Financials
Period Ending Jun 30, 2012 Jun 30, 2011 Jun 30, 2010 Jun 30, 2009
Total Revenue 1,883 1,558 1,122 1,197
Cost of Revenue 1,137 859 550 577
Gross Profit 746 698 572 621
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 875 706 744 1,823
Non-Recurring Items - - 878 -
Other - - - -
Operating Income (129) (8) (1,049) (291)
Income From Continuing Operations

Add'l Income/Expense Items 136 235 - 59
Earnings Before Interest and Tax 7 227 (1,049) (231)
Interest Expense 20 113 78 86
Earnings Before Tax (13) 114 (1,127) (317)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 40 349 (1,127) (317)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (13) 114 (1,127) (317)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (13) 114 (1,127) (317)

PFSD Pacific Sands, Inc. Research DD Guide

PFSD Pacific Sands, Inc. Stock Message Board http://investorshangout.com/search?q=PFSD&...mp;yt0=Go!
PFSD Pacific Sands, Inc. Stock Quote http://www.otcmarkets.com/stock/PFSD/quote
PFSD Pacific Sands, Inc. Stock Chart http://www.otcmarkets.com/stock/PFSD/chart
PFSD Pacific Sands, Inc. Company Info http://www.otcmarkets.com/stock/PFSD/company-info
PFSD Pacific Sands, Inc. Recent News http://www.otcmarkets.com/stock/PFSD/news
PFSD Pacific Sands, Inc. Financials http://www.otcmarkets.com/stock/PFSD/financials
PFSD Pacific Sands, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/PFSD/filings
PFSD Pacific Sands, Inc. Short Sales http://www.otcmarkets.com/stock/PFSD/short-sales
PFSD Pacific Sands, Inc. Insider Disclosure http://www.otcmarkets.com/stock/PFSD/insider-transactions
PFSD Pacific Sands, Inc. Research Reports http://www.otcmarkets.com/stock/PFSD/research
PFSD Pacific Sands, Inc. Summary http://finance.yahoo.com/q?s=PFSD
PFSD Pacific Sands, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=PFSD+Historical+Prices
PFSD Pacific Sands, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=PFSD
PFSD Pacific Sands, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=PFSD+Basic+Chart
PFSD Pacific Sands, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PFSD+Basic+Tech.+Analysis
PFSD Pacific Sands, Inc. Headlines http://finance.yahoo.com/q/h?s=PFSD+Headlines
PFSD Pacific Sands, Inc. Press Releases http://finance.yahoo.com/q/p?s=PFSD+Press+Releases
PFSD Pacific Sands, Inc. Company Profile http://finance.yahoo.com/q/pr?s=PFSD+Profile
PFSD Pacific Sands, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=PFSD+Key+Statistics
PFSD Pacific Sands, Inc. Industry http://finance.yahoo.com/q/in?s=PFSD+Industry
PFSD Pacific Sands, Inc. Major Holders http://finance.yahoo.com/q/mh?s=PFSD+Major+Holders
PFSD Pacific Sands, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=PFSD+Insider+Transactions
PFSD Pacific Sands, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=PFSD+Insider+Roster
PFSD Pacific Sands, Inc. Income Statement http://finance.yahoo.com/q/is?s=PFSD
PFSD Pacific Sands, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=PFSD
PFSD Pacific Sands, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=PFSD+Cash+Flow&annual
PFSD Pacific Sands, Inc. Nasdaq http://www.nasdaq.com/symbol/PFSD
PFSD Pacific Sands, Inc. Market Watch http://www.marketwatch.com/investing/stock/PFSD
PFSD Pacific Sands, Inc. Bloomberg http://www.bloomberg.com/quote/PFSD:US
PFSD Pacific Sands, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=PFSD
PFSD Pacific Sands, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=PFSD
PFSD Pacific Sands, Inc. Barchart http://www.barchart.com/quotes/stocks/PFSD
PFSD Pacific Sands, Inc. OTC Short Report http://otcshortreport.com/index.php?index=PFSD
PFSD Pacific Sands, Inc. Investopedia http://www.investopedia.com/markets/stocks/PFSD/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading